Risk Factors for Candidemia as Compared with Patients with Negative Blood Cultures Placed on Empiric Micafungin

por Carr, Amy, Berhe, Mezgebe
Publicado 2017

2442. Outcomes in ESBL Bacteremia Empirically Treated With Piperacillin/Tazobactam or Carbapenems

por John, Reeba, Colley, Peter, Nguyen, Hoa, Berhe, Mezgebe
Publicado 2018

1993. Impact of Pharmacist Intervention in Response to Rapid Molecular Testing Results of Blood Cultures

por Baskett, Lauren, Colley, Peter, Nguyen, Hoa L, Berhe, Mezgebe
Publicado 2019

2143. Incidence of Infection in Patients Receiving Short vs. Long Duration of Antimicrobial Prophylaxis in Neurosurgery

por Bast, Chelsea, Colley, Peter, Roth, Jennifer, Nguyen, Hoa, Naftalis, Richard, Berhe, Mezgebe
Publicado 2018

902. Selection of Antibiotics for Prophylaxis of Left Ventricular Assist Device Surgical Infections: More is Not More

por Nguyen, Peter T, Sam, Teena, Colley, Peter, Van Zyl, Johanna, Berhe, Mezgebe, Meyer, Dan
Publicado 2020

661. Ibalizumab Efficacy and Safety Through 48 Weeks of Treatment: Results of an Expanded Access Protocol (TMB-311)

por Emu, Brinda, DeJesus, Edwin, Berhe, Mezgebe, Leider, Jason, Creticos, Catherine, Weinheimer, Steve, Cohen, Zvi
Publicado 2019

1028. Long-term Follow-up After a Switch to Bictegravir, Emtracitabine, Tenofovir Alafenamide from Dolutegravir, Abacavir, Lamivudine

por Brar, Indira, Ruane, Peter, Ward, Douglas, Molina, Jean-michel, Mills, Anthony, Berhe, Mezgebe, Brinson, Cynthia, Rampogal, Moti, Benson, Paul, Henry, Keith, Huang, Hailin, Andreatta, Kristen, Martin, Hal
Publicado 2020

1251. 5-year outcomes of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as initial treatment of HIV-1 in adults with high baseline HIV-1 RNA and/or low CD4 count in two...

por Ramgopal, Moti, Wurapa, Anson, Baumgarten, Axel, Berhe, Mezgebe, Pozniak, Anton, Orkin, Chloe, Tiraboschi, Juan Manuel, Hagins, Debbie P, Huang, Hailin, Andreatta, Kristin, Unger, Nathan, Hindman, Jason, Martin, Hal, Baeten, Jared, Osiyemi, Olayemi
Publicado 2022

1596. Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multi-Drug Resistant HIV: Week 104 Results

por Ogbuagu, Onyema, DeJesus, Edwin, Berhe, Mezgebe, Richmond, Gary J, Ruane, Peter J, Sinclair, Gary I, Ramgopal, Moti N, Sanchez, William, Crofoot, Gordon E, Margot, Nicolas A, Wang, Hui, Dvory-Sobol, Hadas, Rhee, Martin, Baeten, Jared, Segal-Maurer, Sorana
Publicado 2023

Dolutegravir/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV

por Rolle, Charlotte-Paige, Berhe, Mezgebe, Singh, Tulika, Ortiz, Roberto, Wurapa, Anson, Ramgopal, Moti, Leone, Peter A., Matthews, Jessica E., Dalessandro, Marybeth, Underwood, Mark R., Angelis, Konstantinos, Wynne, Brian R., Merrill, Deanna, Nguyen, Christopher, van Wyk, Jean, Zolopa, Andrew R.
Publicado 2021

75. High Rates of Virologic Suppression with DTG/3TC in Newly Diagnosed Adults with HIV-1 Infection and Baseline Viral Load >500,000 c/mL: 48-Week Subgroup Analysis of the STAT Stu...

por Rolle, Charlotte-Paige M, Berhe, Mezgebe, Singh, Tulika, Ortiz, Roberto, Wurapa, Anson K, Ramgopal, Moti, Jayaweera, Dushyantha, Leone, Peter, Matthews, Jessica, Cupo, Michael, Underwood, Mark, Angelis, Kostas, Wynne, Brian, Merrill, Deanna, Nguyen, Christopher T, van Wyk, Jean A, Zolopa, Andrew
Publicado 2021

Sustained Virologic Suppression With Dolutegravir/Lamivudine in a Test-and-Treat Setting Through 48 Weeks

por Rolle, Charlotte-Paige, Berhe, Mezgebe, Singh, Tulika, Ortiz, Roberto, Wurapa, Anson, Ramgopal, Moti, Jayaweera, Dushyantha T, Leone, Peter A, Matthews, Jessica E, Cupo, Michael, Underwood, Mark R, Angelis, Konstantinos, Wynne, Brian R, Merrill, Deanna, Nguyen, Christopher, van Wyk, Jean, Zolopa, Andrew R
Publicado 2023

Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine

por Moreira, Edson D., Kitchin, Nicholas, Xu, Xia, Dychter, Samuel S., Lockhart, Stephen, Gurtman, Alejandra, Perez, John L., Zerbini, Cristiano, Dever, Michael E., Jennings, Timothy W., Brandon, Donald M., Cannon, Kevin D., Koren, Michael J., Denham, Douglas S., Berhe, Mezgebe, Fitz-Patrick, David, Hammitt, Laura L., Klein, Nicola P., Nell, Haylene, Keep, Georgina, Wang, Xingbin, Koury, Kenneth, Swanson, Kena A., Cooper, David, Lu, Claire, Türeci, Özlem, Lagkadinou, Eleni, Tresnan, Dina B., Dormitzer, Philip R., Şahin, Uğur, Gruber, William C., Jansen, Kathrin U.
Publicado 2022